- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neoplasm, Residual in United States
Total 49636 results
-
NorthShore University HealthSystemCompletedResidual Neuromuscular Blockade in Elderly PatientsUnited States
-
Fred Hutchinson Cancer CenterJazz PharmaceuticalsTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2 | Myeloid NeoplasmUnited States
-
King's College Hospital NHS TrustRecruiting
-
Lumicell, Inc.TerminatedProstate Cancer | Neoplasm, ResidualUnited States
-
Wuerzburg University HospitalRoyal Marsden NHS Foundation TrustCompletedPain | Neoplasm Metastasis | Neoplastic Processes | Neoplasm, Residual | Neoplasm Recurrence, LocalSwitzerland, Netherlands, Germany, United Kingdom
-
University of Michigan Rogel Cancer CenterJanssen Scientific Affairs, LLCActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | Recurrent B Acute Lymphoblastic LeukemiaUnited States
-
Center for International Blood and Marrow Transplant...MedImmune LLC; National Marrow Donor Program; Pediatric Blood and Marrow Transplant... and other collaboratorsTerminatedAcute Lymphoblastic Leukemia (ALL)United States
-
Therapeutic Advances in Childhood Leukemia ConsortiumGenzyme, a Sanofi CompanyTerminatedMinimal Residual Disease | Leukemia, Lymphoblastic, Acute | Leukemia, Myelogenous, AcuteUnited States
-
University of WashingtonCompletedResidual Paralysis, Post AnesthesiaUnited States
-
Astellas Pharma Global Development, Inc.No longer availableAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsAustralia, Italy, United Kingdom
-
Crystal Mackall, MDCalifornia Institute for Regenerative Medicine (CIRM)Active, not recruitingB Acute Lymphoblastic Leukemia | Philadelphia Chromosome Positive | Minimal Residual Disease | CD19 PositiveUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); Invivoscribe, Inc.; T-Cell Leukemia Lymphoma...Completed
-
University of WashingtonNational Cancer Institute (NCI)TerminatedB Acute Lymphoblastic Leukemia | Recurrent Acute Lymphoblastic Leukemia | Minimal Residual Disease | T Acute Lymphoblastic LeukemiaUnited States
-
Indiana UniversityUnited States Department of DefenseCompletedAmputation | Prosthesis User | Residual LimbsUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...Active, not recruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myelodysplastic/Myeloproliferative Neoplasm | Minimal Residual Disease | Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable | Acute Myeloid Leukemia in RemissionUnited States
-
AmgenRecruitingB-precursor Acute Lymphoblastic LeukemiaUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingLower Limb Amputation Below Knee (Injury) | Diurnal Residual Limb Fluid Volume FluctuationUnited States
-
Sellas Life Sciences GroupUnknownMultiple Myeloma | Minimal Residual Disease | High-Risk CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingB Acute Lymphoblastic Leukemia | Philadelphia Chromosome Positive | Minimal Residual Disease | Adult Acute Lymphoblastic Leukemia in Complete RemissionUnited States
-
Memorial Sloan Kettering Cancer CenterAdaptive BiotechnologiesRecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)United States
-
Massachusetts General HospitalTesaro, Inc.RecruitingTriple Negative Breast Cancer | Residual DiseaseUnited States
-
University of BathUniversity of Southampton; Royal United Hospitals Bath NHS Foundation Trust; Great...CompletedChronic Lymphocytic Leukemia | Minimal Residual DiseaseUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Minimal Residual Disease | NSCLC Stage IV | Nsclc | Metastatic Non Small Cell Lung CancerUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingMantle Cell Lymphoma | CD20 PositiveUnited States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Mayo Clinic; University of Pennsylvania; University...Active, not recruitingAggressive | B-cell Non-Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedMinimal Residual Disease | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive in RemissionUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States
-
Henry Ford Health SystemWithdrawnResidual Neuromuscular BlockadeUnited States
-
NorthShore University HealthSystemT4 AnalyticsTerminatedResidual Neuromuscular BlockadeUnited States
-
Janssen Research & Development, LLCActive, not recruiting
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Acute Myeloid Leukemia Post Cytotoxic TherapyUnited States
-
Amgen Research (Munich) GmbHCompletedB-cell Acute Lymphoblastic LeukemiaAustria, Belgium, France, Germany, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, United Kingdom
-
University of PennsylvaniaUniversity of California, San FranciscoTerminatedPatients With Residual or Reccurent EGFRvIII+ GliomaUnited States
-
University of Texas Southwestern Medical CenterCompletedResidual Neuromuscular BlockadeUnited States
-
NorthShore University HealthSystemCompleted
-
Mayo ClinicEnrolling by invitation
-
Mayo ClinicCompletedResidual Neuromuscular BlockadeUnited States
-
NorthShore University HealthSystemCompletedResidual Neuromuscular BlockadeUnited States
-
AmgenTerminatedHigh-risk Diffuse Large B-cell LymphomaUnited States, Italy, Belgium, Switzerland, Australia, France, Greece
-
Mayo ClinicCompletedResidual Neuromuscular BlockadeUnited States, France, Hungary
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Minimal Residual Disease | Hematopoietic Cell Transplantation Recipient | Acute Myeloid Leukemia in Remission | Acute Lymphoblastic Leukemia in RemissionUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Ziopharm OncologyCompletedAcute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Minimal Residual Disease | Small Lymphocytic Lymphoma | Acute Biphenotypic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia | CD19 Positive | Blasts 5 Percent or More of Bone Marrow Nucleated CellsUnited States
-
Crystal Mackall, MDRecruitingRecurrent Adult Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | Philadelphia Chromosome Positive | Refractory Acute Lymphoblastic Leukemia | Minimal Residual Disease | CD19 PositiveUnited States
-
Mayo ClinicCompletedResidual Neuromuscular BlockadeUnited States, Hungary
-
Medicontur Medical Engineering LtdMedevise ConsultingRecruitingRefractive Errors | Presbyopia | Residual AstigmatismBelgium, France, Spain, United Kingdom
-
OhioHealthCompletedNeuromuscular Blockade | Pulmonary ComplicationUnited States
-
University of WashingtonCompletedResidual Neuromuscular BlockadeUnited States